Transformation of hepatitis C antiviral treatment in a national healthcare system following the introduction of direct antiviral agents.

Moon, A M; Green, P K; Berry, K; Ioannou, G N

Moon, A M; Green, P K; Berry, K; Ioannou, G N.

Afiliación

Moon AM; Divisions of General Internal Medicine, University of Washington, Seattle, WA, USA.
Green PK; Health Services Research and Development, Veterans Affairs Puget Sound Healthcare System, Seattle, WA, USA.
Berry K; Health Services Research and Development, Veterans Affairs Puget Sound Healthcare System, Seattle, WA, USA.
Ioannou GN; Divisions of General Internal Medicine, University of Washington, Seattle, WA, USA.

Aliment Pharmacol Ther ; 45(9): 1201-1212, 2017 05.

Article en En | MEDLINE | ID: mdl-28271521

Asunto(s)

Antivirales/uso terapéutico; Hepatitis C/tratamiento farmacológico; Quimioterapia Combinada/tendencias; Femenino; Hepacivirus/genética; Hepatitis C/sangre; Hepatitis C/virología; Humanos; Masculino; Persona de Mediana Edad; National Health Insurance, United States; ARN Viral/sangre; Estados Unidos; United States Department of Veterans Affairs

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Antivirales / Hepatitis C Límite: Female / Humans / Male / Middle aged País/Región como asunto: America do norte Idioma: En Revista: Aliment Pharmacol Ther Asunto de la revista: FARMACOLOGIA / GASTROENTEROLOGIA / TERAPIA POR MEDICAMENTOS Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google